购物车
- 全部删除
- 您的购物车当前为空
NEO2734 (EP31670) 是一种具有口服活性的选择性 p300/CBP 和 BET 溴结构域抑制剂,其 IC50值均小于30 nM,可用于前列腺癌的研究。
为众多的药物研发团队赋能,
让新药发现更简单!
NEO2734 (EP31670) 是一种具有口服活性的选择性 p300/CBP 和 BET 溴结构域抑制剂,其 IC50值均小于30 nM,可用于前列腺癌的研究。
规格 | 价格 | 库存 | 数量 |
---|---|---|---|
1 mg | ¥ 925 | 现货 | |
5 mg | ¥ 2,490 | 现货 | |
10 mg | ¥ 3,720 | 现货 | |
25 mg | ¥ 5,880 | 现货 | |
50 mg | ¥ 8,290 | 现货 | |
100 mg | ¥ 10,900 | 现货 | |
500 mg | ¥ 22,300 | 现货 | |
1 mL x 10 mM (in DMSO) | ¥ 2,650 | 现货 |
产品描述 | NEO2734 (EP31670) is an orally active and selective inhibitor of p300/CBP and BET bromodomain(IC50 of <30 nM for both p300/CBP and BET bromodomains). |
体外活性 | NEO2734, a novel dual inhibitor of BET and CBP/p300, is active in both hotspot mutant (F133V) and non-hotspot mutant (Q165P) PCa cells in vitro and in vivo[1]. |
别名 | EP31670 |
分子量 | 435.44 |
分子式 | C22H24F3N3O3 |
CAS No. | 2081072-29-7 |
Smiles | Cc1cc(cn(C)c1=O)-c1ccc2nc(C3CCOCC3)n(CCOC(F)(F)F)c2c1 |
密度 | 1.35 g/cm3 (Predicted) |
存储 | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. | ||||||||||||||||||||||||||||||
溶解度信息 | DMSO: 27.5 mg/mL (63.15 mM) | ||||||||||||||||||||||||||||||
溶液配制表 | |||||||||||||||||||||||||||||||
DMSO
|
版权所有©2015-2024 TargetMol Chemicals Inc.保留所有权利.
评论内容